BioStock: Arcede approaching dosing in tox study

When reporting on first quarter of 2023, Arcede Pharma have an eventful period to look back on. Now all eyes are on the final part of the toxicology programme, where dosing starts in June. BioStock contacted CEO Mia Lundblad to hear her thoughts on the past quarter.

Read the full article at biostock.se:

https://www.biostock.se/en/2023/05/arcede-approaching-dosing-in-tox-study/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se